Preliminary Experience with 3-Tesla MRI and Cushing s Disease

Similar documents
October 13, Surgical Nuances to Managing Cushing s Disease. Cortisol Regulation. Cushing s Syndrome Excess Cortisol. Sandeep Kunwar, M.D.

TABLES. Imaging Modalities Evidence Tables Table 1 Computed Tomography (CT) Imaging. Conclusions. Author (Year) Classification Process/Evid ence Class

Imaging pituitary gland tumors

High resolution pituitary gland MRI at 7.0 tesla: a clinical evaluation in Cushing s disease

Repeat transsphenoidal surgery for Cushing's disease

High-resolution 18 F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease

CUSHING'S SYNDROME. Bharath University, Chrompet, Chennai, Tamil Nadu, India

Pituitary Macroadenoma with Superior Orbital Fissure Syndrome

RADIOANATOMY OF SELLA TURCICA

Imaging The Turkish Saddle. Russell Goodman, HMS III Dr. Gillian Lieberman

CUSHING SYNDROME Dr. Muhammad Sarfraz

What about Cushing s disease differs from the other types

False-positive inferior petrosal sinus sampling in the diagnosis of Cushing s disease

University of Michigan continues fine-tuning neuro ExamCards

Magnetic Resonance Imaging. Basics of MRI in practice. Generation of MR signal. Generation of MR signal. Spin echo imaging. Generation of MR signal

No Financial Interest

MR Advance Techniques. Vascular Imaging. Class II

Therapeutic Objectives. Cushing s Disease Surgical Results. Cushing s Disease Surgical Results: Macroadenomas 10/24/2015

Silent ACTHoma: A subclinical presentation of Cushing s disease in a 79 year old male

X/97/$03.00/0 Vol. 82, No. 6 Journal of Clinical Endocrinology and Metabolism Copyright 1997 by The Endocrine Society

TABLES. Table 1: Imaging. Congress of Neurological Surgeons Author (Year) Description of Study Classification Process / Evidence Class

Neuroradiology MR Protocols

3D high-resolution MR imaging can provide reliable information

PITUITARY PARASELLAR LESIONS. Kim Learned, MD

Sensitivity and Specificity in Detection of Labral Tears with 3.0-T MRI of the Shoulder

ACR MRI Accreditation: Medical Physicist Role in the Application Process

(3) Pituitary tumours

Methods. Yahya Paksoy, Bülent Oğuz Genç, and Emine Genç. AJNR Am J Neuroradiol 24: , August 2003

Long term outcome following repeat transsphenoidal surgery for recurrent endocrine-inactive pituitary adenomas

Pituitary adenomas in childhood and adolescence ISABELLE L. RICHMOND, M.D., PH.D., AND CHARLES B. WILSON, M.D.

The Effects of Music intervention on Functional connectivity. Supplemental Information

Studies on the diagnosis and treatment of canine Cushing s disease

W. CHRISTOPHER FOX, M.D., 1 SCOTT WAWRZYNIAK, 2 AND WILLIAM F. CHANDLER, M.D. 1. be very useful during transsphenoidal pituitary surgery as well.

Magnetic Resonance Angiography

Somatotroph Pituitary Adenomas (Acromegaly) The Diagnostic Pathway (11-2K-234)

Pituitary adenomas are a diverse group of tumors arising from the. The Prevalence of Pituitary Adenomas. A Systematic Review

Adrenocorticotropic hormone dependent Cushing s Syndrome: Sensitivity and Specificity of Inferior Petrosal Sinus Sampling

Dynamic CT of the Laterosellar Extradural Venous Spaces

CLINICALLY SILENT ACTH CROOKE S CELL ADENOMA PRESENTING AS UNILATERAL EAR PAIN

SHORTLY AFTER ITS FIRST DEpiction

Intrasphenoidal Rathke's Cleft Cyst: Case presentation and review of the literature

Part II - Revising the sellar and parasellar region: differential diagnosis of a sellar region mass

Pituitary Tumors and Incidentalomas. Bijan Ahrari, MD, FACE, ECNU Palm Medical Group

The Low Sensitivity of Fluid-Attenuated Inversion-Recovery MR in the Detection of Multiple Sclerosis of the Spinal Cord

THE IMAGING IN CUSHING S DISEASE

See the latest estimates for new cases of pituitary tumors in the US and what research is currently being done.

Half-Fourier Acquisition Single-Shot Turbo Spin-Echo (HASTE) MR: Comparison with Fast Spin-Echo MR in Diseases of the Brain

cc/kg mmol/kg ADH i- Incidental ii- Hour glass iii- Diabetes Insipidus iv- Centeral diabetes insipidus v -Supra optic vi- Median emminance iii

CUSHING S SYNDROME. Chapter 8. Case: A 43-year-old man with delusions

MRI Abdomen Protocol Pancreas/MRCP with Contrast

Petrosal Sinus Sampling in the Diagnosis of Cushing's Syndrome: Preliminary Experience in University of Malaya Medical Centre

MR Flow Imaging in Vascular Malformations Using Gradient Recalled Acquisition

Visualization strategies for major white matter tracts identified by diffusion tensor imaging for intraoperative use

UW MEDICINE PATIENT EDUCATION. Cushing s Syndrome DRAFT. What is Cushing s syndrome? What is cortisol? What are the symptoms of Cushing s syndrome?

TREATMENT OF CUSHING S DISEASE

How Much Tesla Is Too Much?

Spontaneous remission of acromegaly and Cushing s disease following pituitary apoplexy: Two case reports

CUSHING S SYNDROME AND CUSHING S DISEASE

Optimized phase contrast MRV technique outperforms timeof-flight in the diagnosis of cerebral venous thrombosis

Prolactin-Secreting Pituitary Adenomas (Prolactinomas) The Diagnostic Pathway (11-2K-234)

Clinical Applications

Long-term results of gamma knife surgery for growth hormone producing pituitary adenoma: is the disease difficult to cure?

Cerebral MR Venography: Normal Anatomy and Potential Diagnostic Pitfalls

Visual pathways in the chiasm

Added value of MR myelography using 3D COSMIC sequence in the diagnosis of lumbar canal stenosis: comparison with routine MR imaging

Original Article. Abstract. Introduction. Thinesh Kumran 1,2, Saffari Haspani 1,2, Jafri Malin Abdullah 1,4, Azmi Alias 1,2, Fan Rui Ven 3

SIPAP: A new MR classification for pituitary adenomas

Improving postoperative MR imaging of pituitary macroadenomas: comparison of full and reduced dose of gadopentetate dimeglumine

Undetectable postoperative cortisol does not always. predict long-term remission in Cushing s disease: a single centre audit*

Gamma knife surgery in management of secretory pituitary adenoma Preliminary evaluation of role, efficacy and safety

CT is generally the preferred imaging technique in the assessment

Clinical application of 3.0 T proton MR spectroscopy in evaluation of pancreatic diseases

Laurie A. Loevner, MD

NANOS Patient Brochure

Impact of Gamma Knife Radiosurgery on the neurosurgical management of skull-base lesions: The Combined Approach

C h a p t e r 3 8 Cushing s Syndrome : Current Concepts in Diagnosis and Management

Downloaded from journal.bums.ac.ir at 20:00 IRST on Saturday October 6th " # $% & '( % ) *+!

NEURO PROTOCOLS MRI NEURO PROTOCOLS (SIEMENS SCANNERS)

The Journal of Bioscience and Medicine 3, 1 (2013) Article

Assessment of Adipose Tissue from Whole Body 3T MRI Scans

Abstract. Introduction

FieldStrength. Achieva 3.0T enables cutting-edge applications, best-in-class MSK images

Endogenous Cushing s syndrome: The Philippine general hospital experience

Repeatability of 2D FISP MR Fingerprinting in the Brain at 1.5T and 3.0T

MR Imaging of Pituitary Adenoma: CT, Clinical, and

Sandostatin LAR for functional neuroendocrine tumor in MEN 1

RECENT ADVANCES IN CLINICAL MR OF ARTICULAR CARTILAGE

Supplementary information Detailed Materials and Methods

Procedia - Social and Behavioral Sciences 159 ( 2014 ) WCPCG 2014

Time-resolved Magnetic Resonance Angiography for assessment of recanalization after coil embolization of visceral artery aneurysms

Broersen et al. Orphanet Journal of Rare Diseases (2019) 14:64 (Continued on next page)

Pituitary Macroadenoma Joseph Junewick, MD FACR

Anatomy of the Junction of the Inferior Petrosal Sinus and the Internal Jugular Vein

Petrosal Sinus Sampling in diagnostic evaluation of ACTHdependent Cushing Syndrome: A Pictorial Review.

Brain Tumors. Andrew J. Fabiano, MD FAANS. Associate Professor of Neurosurgery Roswell Park Cancer Institute SUNY at Buffalo School of Medicine

Infraclavicular brachial plexus blocks have been designed

Supplementary Online Content

Coexisting Rathke Cleft Cyst and Pituitary Adenoma Presenting with Pituitary Apoplexy: Report of Two Cases

NIH Public Access Author Manuscript Otolaryngol Head Neck Surg. Author manuscript; available in PMC 2011 August 1.

Transcription:

TECHNICAL NOTE Preliminary Experience with 3-Tesla MRI and Cushing s Disease LouisJ.Kim,M.D., 1 Gregory P. Lekovic, M.D., Ph.D., J.D., 1 William L.White, M.D., 1 and John Karis, M.D. 2 ABSTRACT Because radiographic visualization of a pituitary microadenoma is frequently difficult, we hypothesized that microadenomas associated with Cushing s disease may be better resolved and localized via acquisition with 3-Tesla (3T) compared with standard 1.5-Tesla (1.5T) magnetic resonance imaging (MRI). Five patients (four females, one male; age range, 14 to 50 years old) with endocrine and clinical confirmation of Cushing s disease underwent 1.5T and 3T MRI and corticotropin-releasing hormone stimulation/inferior petrosal sinus sampling (IPSS) as part of their preoperative evaluation. All patients underwent a transnasal trans-sphenoidal pituitary adenomectomy. In two cases, tumor could not be localized on either 1.5T or 3T MRI on the initial radiologist s review. In two other cases, the 1.5T images delineated the tumor location, but it was more clearly defined on 3T MRI. In a fifth case, the 1.5T MRI showed a probable right-sided adenoma. However, on both 3T MRI and at surgical exploration the tumor was localized on the left side. Therefore, in three of five cases, 3T MRI either more clearly defined tumors seen on 1.5T MRI or predicted the location of tumor contrary to the 1.5T images. IPSS identified the correct side of the tumor in two patients, an incorrect location in two patients, and was indeterminate in one patient. In certain cases 3T MRI is a new tool that may ameliorate imaging difficulties associated with adrenocorticotrophic hormone-secreting pituitary adenomas. Its role in the diagnostic evaluation of Cushing s disease will be better defined with further experience. KEYWORDS: 3-Tesla MRI, Cushing s disease, pituitary gland, imaging 1 Division of Neurological Surgery and 2 Division of Neuroradiology, Barrow Neurological Institute, St. Joseph s Hospital and Medical Center, Phoenix, Arizona. Address for correspondence and reprint requests: William L. White, M.D., c/o Neuroscience Publications, Barrow Neurological Institute, 350 W. Thomas Road, Phoenix, AZ 85013 (e-mail: neuropub@chw.edu). Skull Base 2007;17:273 278. Copyright # 2007 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel: +1(212) 584-4662. Received: May 4, 2007. Accepted: May 15, 2007. Published online: July 18, 2007. DOI 10.1055/s-2007-985196. ISSN 1531-5010. 273

274 SKULL BASE/VOLUME 17, NUMBER 4 2007 Surgical exploration for Cushing s disease in the absence of confirmation by imaging or lateralization by inferior petrosal sinus sampling (IPSS) can lower cure rates. 1 3 Although standard magnetic resonance imaging (MRI) scanners use 1.5T magnets, MRI with stronger magnetic field strength may offer improved image quality and spatial resolution in conditions with subtle differences between normal and abnormal tissue. 4,5 We hypothesized that microadenomas associated with Cushing s disease might be visualized with better resolution and accuracy using high-strength MRI. We present five cases of adrenocorticotrophic hormone (ACTH)-secreting adenomas that showed ambiguous radiographic evidence of tumor on standard MRI. Subsequently, 3T MRI was used to assess the utility of this modality in identifying adenomas associated with Cushing s disease. MATERIALS AND METHODS Patients Five patients (four females, one male; age range, 14 to 50 years old) with endocrine and clinical confirmation of Cushing s disease underwent 1.5T and 3T MRI as part of their preoperative evaluation. Their hospital and office clinic records were reviewed retrospectively. At presentation, their symptoms included hypertension, truncal obesity, headaches, buffalo hump, moon facies, abdominal striae, and hypertension. All patients underwent corticotropin-releasing hormone stimulation and IPSS, which was lateralized in four patients. In the fifth patient, asymmetric venous anatomy precluded left-sided sampling. All patients underwent a transnasal, trans-sphenoidal pituitary adenomectomy. Magnetic Resonance Imaging Technique Conventional 1.5 T MRI was performed at outside imaging facilities, and films were reviewed. 3T scans were obtained from a GE (General Electric, Milwaukee, WI) 3T MRI scanner running VH3 level software. Pre- and postcontrast MRIs were obtained using an inversion prepared three-dimensional (3D) spoiled gradient-recalled (MPRAGE) sequences in the coronal plane. The scan parameters were as follows: repetition time ¼ 5.2 milliseconds; inversion preparation time ¼ 300 milliseconds; echo time ¼ 2.1 milliseconds; flip angle ¼ 13 degrees; slice thickness ¼ 1.8 mm; field of view (FOV) ¼ 24 cm; scan matrix ¼ 256 256 63 at FOV in phase; reconstruction matrix ¼ 512 512 124; number of excitations (NEX) ¼ 2; and relative bandwidth (rbw) ¼ 63.4 khz. Imaging findings were based on the radiologists official report at the time of the study (Table 1). Table 1 Patient Characteristics, Tumor Imaging Results, and Inferior Petrosal Sinus Sampling Lateralization Patient Age/Sex 1.5T MRI 3T MRI IPSS 1 37/F Stalk deviation Hypodensity Rt anterior Surgical Location of Tumor Retrospective Reanalysis Lt side Rt anterior Better delineated on 3T 2 14/F Enlarged, symmetric gland Enlarged, symmetric gland Rt side Anterior midline Indeterminate on 1.5T or 3T 3 35/F Slight Lt hypodensity Clear Lt Lt side Lt side Better delineated on 3T hypodensity 4 50/F Indeterminate Indeterminate Lt side Lt side Indeterminate on 1.5T or 3T 5 34/M Rt-sided tumor Lt-sided tumor Equivocal Lt side Better delineated on 3T T, Tesla; IPSS, inferior petrosal sinus sampling; F, female; M, male; Lt, left; Rt, right.

3T MRI AND CUSHING S DISEASE/KIM ET AL 275 RESULTS Imaging Outcomes Based on the 1.5T MRI studies, two patients (cases 1 and 3, Table 1) had correctly lateralized lesions, two patients (cases 2 and 4) had indeterminate lesions, and one patient (case 5) had an incorrectly lateralized lesion. Based on the 3T MRI, two patients (cases 1 and 3, Fig. 1) had adenomas more clearly delineated than on 1.5T MRI, two patients (cases 2 and 4, same as 1.5T MRI) had adenomas in indeterminate locations (Fig. 2), and one patient (case 5) had an adenoma correctly lateralized on the left (Fig. 3). In the latter, 1.5T MRI had incorrectly identified the adenoma as probable on the right side. IPSS identified the correct side of the tumor in two patients (cases 3 and 4), an incorrect location in two patients (cases 1 and 2), and an indeterminate location in one patient (case 5) due to venous asymmetry. A retrospective, side-by-side comparison of 1.5T and 3T MRI was performed by a neuroradiologist (JK). In two cases, evidence of tumor and its location was perceptible and accurate on 1.5T MRI. However, in these same cases, 3T MRI better delineated the lesions. In cases 2 and 4, both 1.5T and 3T MRI failed to identify the presence and location of the tumor. In one of these cases, the intrasellar contents were clearly enlarged and abnormal, but no definite tumor mass could be perceived. In one case (case 5), the tumor was difficult to ascertain on 1.5T MRI but was well delineated as left-sided on 3T MRI. This left-sided abnormality was confirmed at surgery (Table 1). Clinical Outcomes In all cases, the location of the adenoma and neoplastic tissue with ACTH-immunoreactivity was confirmed histologically. During a brief follow-up (range, 5 to 12 months), no patient has shown evidence of recurrent or residual disease. DISCUSSION Unfortunately, absent radiographic evidence of tumor is often associated with Cushing s disease. 6 In such cases, IPSS remains a useful tool in Figure 1 (Case 3) (A) T1-weighted coronal 1.5T MRI with contrast shows slight hypointensity on the left side of the sella (arrow) consistent with a left-sided pituitary mass. (B) T1-weighted 3T coronal MRI with contrast shows marked differentiation of the hypointense tumor (arrow) and surrounding normal gland.

276 SKULL BASE/VOLUME 17, NUMBER 4 2007 Figure 2 (Case 4) (A) T1-weighted coronal 1.5T MRI and (B) 3T MRI with contrast show enhancement of the intrasellar contents with no clear radiographic definition of the tumor. IPSS indicated a strong left-sided ACTH gradient with a high central-to-peripheral ratio. A left-sided ACTH-secreting adenoma was confirmed at surgery. IPSS, inferior petrosal sinus sampling; ACTH, adrenocorticotropic hormone. the diagnostic algorithm; however, its potential for inaccuracy is well documented. 7 9 Given these shortcomings, that the improved resolution and image quality afforded by 3T MRI might better differentiate ACTH-secreting microadenomas from normal gland is an attractive hypothesis. Wolfsberger et al 10 used T1-weighted 3D magnetization-prepared rapid-acquisition gradient-echo sequences on 3T MRI to study 42 Figure 3 (Case 5) (A) T1-weighted coronal 1.5T MRI with contrast shows no clear tumor margins. The radiologist s interpretation stated probable 5.5-mm right-sided pituitary adenoma. IPSS could only be obtained on the right side. (B) T1-weighted coronal 3T MRI shows a left-sided hypointensity relative to the surrounding enhancing gland (arrow). This finding is consistent with a pituitary microadenoma, which was confirmed during surgical exploration. IPSS, inferior petrosal sinus sampling.

3T MRI AND CUSHING S DISEASE/KIM ET AL 277 cavernous sinuses. This modality was used to minimize susceptibility artifacts in the sellar and parasellar region. They concluded that 3T MRI provided superior delineation of an intrasellar tumor involved with the cavernous sinus compared with standard MRI techniques. However, they did not compare standard MRI to 3T MRI with respect to specific tumor types. In fact, the literature lacks any discussion of the potential advantages of 3T MRI compared with 1.5T MRI in identifying ACTH-secreting pituitary adenomas. Our small and highly selected population precludes strong conclusions. Nonetheless, 3T MRI either further delineated or newly demonstrated a pituitary microadenoma in three of the five cases, even though the findings were equivocal in the remaining two cases. In comparison, 1.5T MRI predicted two cases correctly, two equivocally, and one incorrectly. IPSS predicted two cases correctly and two incorrectly; one was technically infeasible. IPSS correctly lateralized the tumor in case 4 but was inaccurate in case 2. Interestingly, 1.5T MRI (case 5) and IPSS (case 1) incorrectly lateralized the tumor in one case each. Although 3T did not incorrectly lateralize a tumor, it failed to determine the site of tumor in two cases. Both 1.5T and 3T MRI were equivocal in the same two cases (cases 2 and 4). That 1.5T and 3T MRI were indeterminate in the same two cases indicates that certain ACTH-secreting microadenomas will likely continue to be indistinguishable from adjacent normal gland, irrespective of the magnet strength used in MRI. When, however, a subtle imaging abnormality exists (e.g., cases 1 and 3), the increased magnetic strength of the 3T scanner may be superior to 1.5T in amplifying these radiographic differences. On the basis of case 5, some adenomas appear to be radiographically indeterminate on 1.5T MRI yet determinate on 3T MRI. Undoubtedly, the subtle differences between 1.5T and 3T MRI will be exploited as refinements in head coils and imaging sequences are introduced. CONCLUSIONS In certain cases, the new tool of 3T MRI may ameliorate the imaging difficulties associated with ACTH-secreting pituitary adenomas. Although the role of 3T MRI needs to be further defined, the modality may be a useful adjunct in the evaluation algorithm for Cushing s disease and in planning the management of certain cases. REFERENCES 1. Kim LJ, Klopfenstein JD, Cheng M, et al. Ectopic intracavernous sinus adrenocorticotropic hormone-secreting microadenoma: could this be a common cause of failed transsphenoidal surgery in Cushing disease? Case report. J Neurosurg 2003;98:1312 1317 2. Sheehan JM, Lopes MB, Sheehan JP, Ellegala D, Webb KM, Laws ER. Results of transsphenoidal surgery for Cushing s disease in patients with no histologically confirmed tumor. Neurosurgery 2000;47:33 36 3. Sheehan JM, Vance ML, Sheehan JP, Ellegala DB, Laws ER. Radiosurgery for Cushing s disease after failed transsphenoidal surgery. J Neurosurg 2000;93:738 742 4. Novak V, Chowdhary A, Abduljalil A, Novak P, Chakeres D. Venous cavernoma at 8 Tesla MRI. Magn Reson Imaging 2003;21:1087 1089 5. Trattnig S, Ba-Ssalamah A, Noebauer-Huhmann IM, et al. MR contrast agent at high-field MRI (3 Tesla). Top Magn Reson Imaging 2003;14:365 375 6. Tabarin A, Laurent F, Catargi B, et al. Comparative evaluation of conventional and dynamic magnetic resonance imaging of the pituitary gland for the diagnosis of Cushing s disease. Clin Endocrinol (Oxf) 1998;49:293 300 7. Doppman JL, Nieman LK, Chang R, et al. Selective venous sampling from the cavernous sinuses is not a more reliable technique than sampling from the inferior petrosal sinuses in Cushing s syndrome. J Clin Endocrinol Metab 1995;80: 2485 2489 8. Oldfield EH, Doppman JL, Nieman LK, et al. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing s syndrome. N Engl J Med 1991;325:897 905 9. Zovickian J, Oldfield EH, Doppman JL, Cutler GBJr, Loriaux DL. Usefulness of inferior petrosal sinus venous endocrine markers in Cushing s disease. J Neurosurg 1988; 68:205 210 10. Wolfsberger S, Ba-Ssalamah A, Pinker K, et al. Application of three-tesla magnetic resonance imaging for diagnosis and surgery of sellar lesions. J Neurosurg 2004; 100:278 286